IDIOPATHIC INFLAMMATORY MYOPATHIES
Clinical trials for IDIOPATHIC INFLAMMATORY MYOPATHIES explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC INFLAMMATORY MYOPATHIES trials appear
Sign up with your email to follow new studies for IDIOPATHIC INFLAMMATORY MYOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on lupus and scleroderma in new trial
Disease control TerminatedThis early-stage study is testing a new treatment called RD06-04, which uses a patient's own immune cells modified to target and attack faulty B cells. The goal is to see if it is safe and tolerable for people with active autoimmune diseases like lupus, scleroderma, and Sjögren's…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 01:01 UTC
-
Immune cell therapy shows promise for Tough-to-Treat autoimmune diseases
Disease control OngoingThis early-stage study tests a new treatment called CNTY-101 for people with severe autoimmune diseases like lupus, scleroderma, and inflammatory myopathies that haven't responded to standard therapies. The treatment uses specially engineered immune cells to target and destroy fa…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE1 • Sponsor: Century Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 00:52 UTC
-
Immune reset: CAR T-Cells take on lupus and vasculitis
Disease control OngoingThis early-stage study tests a single dose of KYV-101, a personalized CAR T-cell therapy, in up to 24 adults with certain autoimmune diseases (like lupus nephritis and vasculitis). The goal is to see if it is safe and can reduce disease activity by targeting and destroying faulty…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE1 • Sponsor: David Porter • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Engineered immune cells take on lupus and scleroderma in early trial
Disease control ENROLLING_BY_INVITATIONThis early-phase study tests a new treatment called Prula-cel for people with certain autoimmune diseases like lupus and scleroderma. Prula-cel uses specially engineered immune cells from a healthy donor to target and attack faulty immune cells that cause disease. The main goals …
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE1 • Sponsor: Adicet Therapeutics • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
Shingles vaccine shows promise for patients with rheumatic conditions
Prevention OngoingThis study looks at how safe and effective the Shingrix vaccine is for people with autoimmune rheumatic diseases like rheumatoid arthritis and lupus, who are at higher risk for shingles. About 2,000 participants will receive the vaccine or a placebo to check for disease flares an…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE4 • Sponsor: University of Sao Paulo General Hospital • Aim: Prevention
Last updated May 15, 2026 11:54 UTC